StemCells Inc - STEM - reported that the FDA has authorized the initiation of a Phase I/II clinical trial of the Company's proprietary HuCNS-SC product candidate (purified human neural stem cells) in dry age-related macular degeneration. On its first quarter fiscal 2012, Green Mountain Coffee Roasters Inc - GMCR - posted GAAP operating income of $145.8 million, compared to $23.3 million in the same period the prior year. Discovery Laboratories Inc - DSCO - reported that AFECTAIR is now registered with the FDA and is cleared to be marketed in the United States. AFECTAIR is a proprietary patient interface technology that simplifies delivery of aerosolized medications to patients requiring ventilator support. ********************************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

• Added by: karmastock
• Date added: 02/02/12
• Video Duration: 01:22
• Category: News
• Number of views: 162
• Tags: StemCells, Green Mountain Coffee, Discovery Laboratories, STEM, GMCR, DSCO, Nasdaq:STEM, Nasdaq:GMCR, Nasdaq:DSCO (GMCR, STEM, DSCO) CRWENewswire Stocks In Action



Post a Comment

To add a comment, please fill out the box below and click on the submit button. Comment:

There are currently no comments for this video